The study of Mendelian diseases and the identification of their causative genes are of great significance in the field of genetics. The evaluation of the pathogenicity of genes and the total number of Mendelian disease genes are both important questions worth studying. However, very few studies have addressed these issues to date, so we attempt to answer them in this study.
Introduction
In recent years, the identification of pathogenic genes for Mendelian diseases (MD) has developed rapidly. Wenger et al. indicated that an average of 266 OMIM phenotypes with known molecular bases and 241 gene-disease associations for MD are reported annually (Wenger et al. 2017) . Currently, more than 5000 single-gene disorders have been reported, and nearly 4000 genes are responsible for them.
The key points in MD research are how to efficiently evaluate the pathogenicity of each gene and how many genes among the ~20,000 protein-coding genes may cause MD.
Variant-level prediction methods are widely used in the identification of MD genes. There are dozens of tools for performing variant-level prediction, such as SIFT (Ng et al. 2003 (Rackham et al. 2015) and GDI (Itan et al. 2015) , which may play an irreplaceable supplementary role in MD gene identification. These existing gene-level prediction tools rely mainly on a single characteristic of genes, which is the intolerance to functional variants, to make predictions.
Although the genic intolerance values produced by these tools may reflect the pathogenicity of genes, they didn't give a cutoff for deeming them pathogenic.
The pathogenicity of genes is decided by more than one kind of factor. If we combine multiple characteristics instead of just one characteristic to do the prediction, we may have a better result.
Machine learning is an efficient method for classification and prediction. It may combine many features from the studied objects and provide a comprehensive judgment of new objects. The development of variant-level prediction tools indicates the ones using machine learning tend to show better performance. The random forest algorithm is a well-developed model of machine learning that can handle multiple features and tolerate samples with missing features. This algorithm is very suitable for predicting the pathogenicity of genes.
In this study, we applied a machine learning approach (random forest algorithm) that combined 201 gene-level characteristics to produce the gene pathogenicity prediction (GPP) score. The GPP score showed better performance than residual variation intolerance score (RVIS) and gene damage index (GDI) in distinguishing MD genes. Our results estimated that a total of 10,399 protein-coding genes were MD genes. The characteristics of GPP score were also analyzed. Gene dominance prediction (GDP) score and gene recessiveness prediction (GRP) score were calculated by the same method to evaluate the inheritance model of MD genes. The 3 scores were integrated in a list called the gene catalog of Mendelian diseases (GCMD). Our results may be applied to MD research, especially for the identification of pathogenic genes. This is the first trial to provide a clear cutoff for judging MD genes and to estimate the total number of them. 
Methods

Data collection and gene standardization
Gene set selection and gene-level characteristic filtration in machine learning approach
To explore a comprehensive method to predict the pathogenicity of genes, we applied a machine learning approach. The gene sets and gene-level characteristics used in machine learning were produced as follows.
Gene set selection: The loss-of-function (LOF) variant tolerant genes were obtained from the KG, GAD and ExAC databases, among which 630 high-quality genes were used as the training set of negative genes, and the remaining 850 genes were used as the testing set of negative genes. To ensure a balance between the number of positive and negative genes used in our model, we extracted and selected 630 and 850 MD genes as the training and testing sets of positive genes, respectively.
Gene-level characteristic filtration: We extracted many gene-level characteristics from ANNOVAR, STRING, Refgene, HomoloGene, GTEx and DOMINO (Quinodoz et al. 2017) , as well as several characteristics calculated by ourselves, including the gene intolerance scores, gene potential damaging scores, and so on. In total, we enrolled 405 characteristics. If some genes were missing a value for a characteristic, we used the median value of other genes to fill it. We excluded genes with missing values for more than 50% of all characteristics. Then, we performed some filtration and finally kept 5 Table 1 ).
characteristics (Supplementary
The details are provided in the Supplementary methods.
Gene pathogenicity prediction score produced by random forest algorithm
After the gene sets and gene-level characteristics were obtained, we adjusted the parameters of the random forest algorithm (ntree and mtry) and built a model with the training gene sets and gene-level characteristics. We applied the model to the testing gene set to evaluate its effect. The 10 most important characteristics of the model were analyzed. Then, the GPP score of all protein-coding genes were calculated by the model, the number of predicted pathogenic and non-pathogenic genes (Np and Nn) of MD were obtained according to their scores (the default cutoff 0.5 was used). Considering the false-positive rate (FPR) and false-negative rate (FNR), we estimated the number of MD genes (Nm) as:
We then collected several disease gene sets and analyzed the prediction accuracy and score distribution of them. The detailed gene sets and the gene selection method are listed in Supplementary Table 2 .
Prediction of dominant and recessive models of Mendelian disease genes
To distinguish dominant genes and recessive genes, we applied the same pipeline we used when calculating the GPP score to calculate the GDP and GRP scores, respectively. Briefly, we collected genes from the autosome that showed dominant, recessive and both inheritance patterns. In our model, 1243 positive genes and 1584 negative genes were used for the GDP score calculation, while 1985 positive genes and 842 negative genes were used for the GRP score calculation. After the filtration, 183
gene-level characteristics were kept. We did not divide the genes into a training and a testing set, and we applied 4X cross-testing to do the calculation (see Supplementary methods).
The 2 scores (GDP and GRP) and GPP score are integrated in Supplementary Table 3 .
Results
The performance of GPP score produced by the random forest algorithm
We applied a machine learning approach (random forest algorithm) to calculate gene pathogenicity prediction (GPP) score. After the adjustment of parameters, 201 gene-level characteristics were used, and we found ntree=500 and mtry=46 to be suitable parameters. When we applied the GPP score produced by this model to the testing gene set, we obtained accuracy of 80%, recall of 93%, FPR of 6 26% and FNR of 10% (the default cutoff 0.5 was used). The receiver operating characteristic (ROC) curve showed an area under the curve (AUC) of 0.87. We compared the performance of the GPP score with that of RVIS and GDI on the testing gene set and found that the GPP score performed significantly better than the other two tools (Fig 1A) . The 10 most important characteristics identified by the mean decrease in the Gini coefficient of the model mainly belonged to 3 categories (gene intolerance scores, variant damage prediction results and gene interaction score) (Fig 1B) . Then, we evaluated the performance of each characteristic on the testing gene set. The ROC curve showed that the AUC ranged from 0.5 to 0.76 (Fig 1C) , which was much lower than that of the GPP score. We collected reported MD genes and susceptible genes from OMIM, LOF variants intolerant genes from ExAC and known pathogenic genes from several resources to evaluate the prediction accuracy of the GPP score. The genes without GPP score were excluded. The cutoff to distinguish pathogenic and non-pathogenic genes of MD was set as 0.5. MD genes showed higher accuracy (92.8%) than that of susceptible genes (74.5%), LOF variants intolerant genes showed even higher accuracy (96.7%), and pathogenic genes showed a bit lower accuracy (87.4%) ( Table 1 ). It was comprehensible that susceptible genes showed lower prediction accuracy because part of them were not MD genes. The accuracy of pathogenic gene set was not that high because a part of pathogenic genes of non-Mendelian diseases were involved. And the results indicated that LOF variants intolerant genes in ExAC may contain massive potential MD genes waiting to be confirmed. The estimation for the number of Mendelian disease genes and the GO analysis In general, the reported_PM and the predicted_PM sets showed little difference, while the predicted_NM set showed larger difference compared to them (Supplementary Fig 1) . We found that the predicted_PM and predicted_NM sets showed little difference compared to the reported_PM set in some GO pathways, such as membrane part (GO:0044425), extra-cellular region (GO:0005576), immune system process (GO:0002376), and so on. In particular, the predicted_NM set showed higher percentage of enrichment compared to the other two sets in two pathways, which were signal transducer activity (GO:0004871) and cell killing (GO:0001906).
GPP score is positively correlated with the severity of disease
Two peaks were observed in the GPP score (Fig 2A) . The proportion of overlap between the genes with different GPP scores and reported MD genes was analyzed. We found that genes with higher scores showed a higher proportion of overlap with reported MD genes, and the proportion ranged from 4.4%
(GPP scores under 0.5) to 30.8% (GPP scores above 0.9) (Fig 2B) . We also examined the distribution of predicted and reported MD genes on each chromosome, but we did not find obvious hot or cold spots (Supplementary Fig 2) . The distribution of the GPP score for several kinds of pathogenic gene set was observed. We found that genes with known inheritance models showed significantly higher scores than susceptibility genes ( Fig   3A) . And we found the scores of LOF genes were higher than those of GOF genes (Wilcoxon rank sum test, p≤0.001) (Fig 3B) . To determine whether the GPP score could reflect the age of onset or severity of the disease, we examined the score distribution of several pathogenic gene sets accordingly. Among several kinds of neurological disease, intellectual disability (ID) and autism spectrum disorder (ASD) tended to show an early age of onset, the onset of schizophrenia (SCZ) mainly occurred in late adolescence, Alzheimer's disease (AD) often occurred in the elderly, and epilepsy (EP) occurred in a wide range of age. The scores of these gene sets showed little difference (Fig 3C) . The pathogenic genes of diseases with severe phenotypes (neuromuscular disease, metabolic disease, congenital heart disease and hereditary tumors) showed higher scores, while the genes of diseases with mild phenotypes (skin diseases such as psoriasis and ichthyosis) showed lower scores. These results indicated GPP score was positively correlated with the severity of disease. Genes of complex diseases (hypertension, obesity and diabetes) and male infertility showed scores between those of severe and mild diseases ( Fig   3D) .
Fig 3 The distribution of GPP score for different pathogenic gene sets
The dominant and recessive patterns for pathogenic genes
We applied the same machine learning approach to calculate GDP score and GRP score to predict dominant and recessive genes. After adjustment of the parameters, we obtained accuracy of 75%, recall of 64%, FPR of 24%, FNR of 25% and AUC of 0.82 for the GDP score and accuracy of 81%, recall of 97%, FPR of 20%, FNR of 15% and AUC of 0.808 for the GRP score. We also checked the score distribution of all MD genes and found that more genes tended to follow the recessive model ( Supplementary Fig 3) . Our prediction results showed that there were 4942 autosomal dominant genes and 10,041 autosomal recessive genes. Considering the FPR and FNR, we estimated that the numbers of real dominant and recessive genes were 5871 and 8537, respectively.
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Discussion
Our results estimate that 10,399 genes are MD genes, which is much more than currently reported number. This is the first time to estimate the total number of MD genes. The estimated number may indicate that there are many pathogenic genes (or lethal genes) of MD waiting to be discovered. Lethal genes are those with important function and the dysfunction of them will cause death before birth.
Lethal genes are rarely identified in disease research, so we wanted to provide a cutoff of the GPP score for lethal genes. We extracted some lethal genes from the Mouse Genome Informatics (MGI) database.
The quartile value of them was 0.888, which may suggest a cutoff of lethal genes.
Analysis of the score distributions of different gene sets showed that the GPP score was positively correlated with disease severity. Infertility is a special kind of disease, which may have a strong influence on the next generation but little influence on the patients themselves. We also analyzed the diseases with different ages of onset and found no significant difference between the scores of these gene sets. These results indicate that the GPP score may reflect disease severity, where severity means the degree of threat to the health or survival of the individuals themselves but not the next generation.
The gene sets we used may contain some non-Mendelian disease genes that influence the results. So, we exclude genes not in the reported MD gene pool and do the analysis again, and similar results are obtained.
In this study, we ultimately calculated 3 gene-level scores to evaluate the pathogenicity of all protein-coding genes and to assign the dominant or recessive model to each MD gene. The GPP score may help to identify MD genes, while the GDP and GRP scores may help to identify which genes follow dominant or recessive models. To explore a wider range of application of our scores, we applied the GPP score to some genes related to schizophrenia identified by GWAS (Li et al. 2017) , and a high proportion (87.3%) of the genes were predicted to be pathogenic. Some diseases are highly related to copy number variations (CNVs), but there may be several genes involved when a responsible CNV is identified. We find the GPP score can significantly distinguish core genes from background genes of CNV, which may help us identify the core genes so that we can obtain accurate targets for later research.
There are some deficiencies in our study. When selecting non-pathogenic genes of MD (negative gene sets), we used the existing variants in public databases to select LOF variants tolerant genes. We didn't find "reported non-pathogenic genes" because it's hard to deem a gene to be non-pathogenic. This may produce some errors, although our analysis verified that the selected genes were generally accurate.
When we applied the GPP score to analyze gene sets of different diseases, we selected only a limited number of diseases and genes. If more diseases and genes had been involved, we might have obtained more convincing results. We also tried to perform the GOF and LOF prediction by the same method, but we did not collect enough GOF genes. We may finish this effort to complement our study when we 
Figure legends
